Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 1 2

Status

Completed 126Unknown 21Terminated 20Recruiting 20Active not recruiting 5Withdrawn 3Suspended 2Not yet recruiting 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5Observational 2

Sponsor

Conditions

Breast Neoplasms 704Carcinoma, Non-Small-Cell Lung 470Prostatic Neoplasms 420Neoplasms 380Multiple Myeloma 264Colorectal Neoplasms 261Lung Neoplasms 247Neoplasm Metastasis 229Melanoma 215Ovarian Neoplasms 191Leukemia, Myeloid, Acute 189Pancreatic Neoplasms 182Squamous Cell Carcinoma of Head and Neck 163Recurrence 147Carcinoma, Renal Cell 145Lymphoma 142Glioblastoma 138Lymphoma, Non-Hodgkin 135Stomach Neoplasms 128Triple Negative Breast Neoplasms 127Brain Neoplasms 124Carcinoma, Hepatocellular 123Leukemia, Lymphocytic, Chronic, B-Cell 122Uterine Cervical Neoplasms 117Head and Neck Neoplasms 117Precursor Cell Lymphoblastic Leukemia-Lymphoma 115Urinary Bladder Neoplasms 113Lymphoma, Large B-Cell, Diffuse 105Sarcoma 102Lymphoma, Follicular 100

Interventions

temsirolimus 1Vorinostat 1Sirolimus 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Active not recruiting × Interventional × Advanced Cancer × Clear all
NCT05408507 2026-02-09

Care Planning Framework in Advanced Cancer (ABC123)

University of Colorado, Denver

Phase NA Active not recruiting
70 enrolled

Advanced Cancer

NCT01087554 2026-01-16

Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer

M.D. Anderson Cancer Center

Phase 1 Active not recruiting
249 enrolled

Advanced Cancer

NCT05735496 2025-08-01

Clinical Trial of the TQB2102 Injection in Patients With Advanced Cancers

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1 Active not recruiting
219 enrolled

Advanced Cancer

NCT04757155 2025-07-17

iCALM

University Health Network, Toronto

Phase NA Active not recruiting
50 enrolled

Advanced Cancer

NCT04435444 2025-07-03

Meaning-Centered Intervention for Muslim Patients Who Are Being Treated for Advanced Cancer

Memorial Sloan Kettering Cancer Center

Phase NA Active not recruiting
19 enrolled

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡